VF
VYGR icon

Virtu Financial’s Voyager Therapeutics VYGR Stock Holding History

Virtu Financial’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$150K Sell
42,897
-34,581
-45% -$131K ﹤0.01% 1023
2026
Q1 		$299K Buy
+77,478
New +$305K 0.01% 815
2025
Q4 		– Sell
-19,937
Closed -$93K – 2294
2025
Q3 		$93K Buy
+19,937
New +$72.1K 0.01% 1055
2025
Q1 		– Sell
-17,692
Closed -$100K – 2094
2024
Q4 		$100K Buy
+17,692
New +$114K 0.01% 1019
2023
Q3 		– Sell
-27,855
Closed -$319K – 1953
2023
Q2 		$319K Buy
+27,855
New +$288K 0.02% 589
2022
Q2 		– Sell
-18,443
Closed -$141K – 2124
2022
Q1 		$141K Buy
18,443
+8,141
+79% +$36.3K 0.01% 898
2021
Q4 		$28K Buy
+10,302
New +$35.1K ﹤0.01% 1464
2017
Q4 		– Sell
-23,171
Closed -$477K – 3078
2017
Q3 		$477K Buy
+23,171
New +$261K 0.02% 967

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Virtu Financial's VYGR Position: Q2 2026 in Review

Virtu Financial reduced its Voyager Therapeutics (VYGR) stake by 45% in Q2 2026, selling an estimated $131K and leaving 42,897 shares worth $150K. The position accounts for ﹤0.01% of the portfolio, ranked #1023.

Virtu Financial first reported a position in VYGR in Q3 2017 and has held it in 8 quarters since. The position peaked at $477K in Q3 2017. 135 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

  • Virtu Financial held 42,897 shares of Voyager Therapeutics worth $150K as of Q2 2026.
  • Virtu Financial sold 34,581 Voyager Therapeutics shares in Q2 2026, an estimated $131K.
  • Voyager Therapeutics made up ﹤0.01% of Virtu Financial's portfolio in Q2 2026, its #1023 holding.
  • Virtu Financial first reported a position in Voyager Therapeutics in Q3 2017 and has held it in 8 quarters since.
  • Virtu Financial's Voyager Therapeutics position peaked at $477K in Q3 2017.
  • 135 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.